MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
1-Year Return
18.92%
This Quarter Return
+7.76%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$311M
AUM Growth
-$18.7M
(-5.7%)
Cap. Flow
-$32.3M
Cap. Flow
% of AUM
-10.36%
Top 10 Holdings %
Top 10 Hldgs %
51.43%
Holding
37
New
9
Increased
4
Reduced
13
Closed
9
Top Buys
| 1 |
United Therapeutics
UTHR
|
+$15.7M |
| 2 |
Insulet
PODD
|
+$12.8M |
| 3 |
Biogen
BIIB
|
+$11.3M |
| 4 |
Zoetis
ZTS
|
+$10.4M |
| 5 |
Incyte
INCY
|
+$9.75M |
Top Sells
| 1 |
Aon
AON
|
+$12.3M |
| 2 |
Baxter International
BAX
|
+$12.1M |
| 3 |
Humana
HUM
|
+$11.6M |
| 4 |
eHealth
EHTH
|
+$11.3M |
| 5 |
Perrigo
PRGO
|
+$11.2M |
Sector Composition
| 1 | Healthcare | 84.92% |
| 2 | Materials | 5.92% |
| 3 | Industrials | 4.21% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FURX
26
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $6.09M | 1.95% |
+69,960
| New | +$6.09M |
|
27
Integra LifeSciences
IART
$1.17B
| $5.94M | 1.91% |
315,698
-309,146
| -49% | -$5.81M |
|
28
Precigen
PGEN
$1.13B
| $5.86M | 1.88% |
+233,371
| New | +$5.86M |
|
|
29
Aon
AON
$80.2B
| – | – |
-146,694
| Closed | -$12.3M |
|
|
30
Baxter International
BAX
$12.3B
| – | – |
-321,015
| Closed | -$12.1M |
|
|
31
eHealth
EHTH
$122M
| – | – |
-243,399
| Closed | -$11.3M |
|
|
32
Humana
HUM
$33.2B
| – | – |
-112,502
| Closed | -$11.6M |
|
33
Marsh & McLennan
MMC
$99.8B
| – | – |
-120,350
| Closed | -$5.82M |
|
|
34
Perrigo
PRGO
$3.06B
| – | – |
-72,955
| Closed | -$11.2M |
|
35
Thermo Fisher Scientific
TMO
$181B
| – | – |
-51,545
| Closed | -$5.74M |
|
|
GNMK
36
DELISTED
GenMark Diagnostics, Inc
GNMK
| – | – |
-223,818
| Closed | -$2.98M |
|
|
MDCO
37
DELISTED
Medicines Co
MDCO
| – | – |
-152,809
| Closed | -$5.9M |
|